A peptide antibiotic, commonly grouped with the aminoglycosides, which is given in combination with other antibiotics for MDR-tuberculosis. .

A peptide mimetic of the C-terminal Cys-Val-Ile-Met of K-Ras4B that potently inhibits FTase (Farnesyltransferase) with IC50 of 0.5 nM.

A peptidic glucagon like peptide 2 (GLP-2) analogue for treatment of type2 diabetes..

A pesticide agent..

A pH-dependent, GluN2B-selective inhibitor of NMDA receptor with IC50 of 0.19 uM at pH6.9, 10-fold selecivity over brain tissue pH 7.6 (IC50=1.8 uM).

A phenolic antioxidant and a selective inducer and activator of Nrf2 that ameliorates doxorubicin-induced cardiotoxicity in vivo.

A phosphate ester prodrug of the HIV-1 protease inhibitor amprenavir with improved solubility..

A picornavirus replication inhibitor by binding to the hydrophobic pocket within the VP1 coat protein, thus stabilizing the virion and blocking its uncoating..

A plant activator of systemic acquired resistance, boosts the production of herbivore-induced plant volatiles.

A plant flavonoid that has been found to inhibit cell proliferation by arresting the cell cycle at the G2/M phase.

A plant metabolite possessing anti-leukemic activity; inhibits the non-receptor kinases, Syk and Lck.

A platinum-containing compound that disrupts STAT3 signaling, inhibits cell growth and induces apoptosis in STAT3-activated cancer cells.

A polyamine oxidase (PAO) inhibitor that inhibits spermine oxidase and N1-acetylpolyamine oxidase with IC50 of 6.1 and 0.02 uM, respectively.

A polyene antifungal antibiotic that works by disrupting the cell membrane of the fungal cells..

A poorly reversible TRAAK inhibitor, shows no activity for non-K2P channels (Kv1.2, Slo1 and GIRK2)..

A poten and selective, ATP-competitive DNA-PK inhibitor with IC50 of 0.19 uM, Ki of 24 nM.

A potent 20S proteasome inhibitor with IC50 of 49 nM (inhibition of proteasomal chymotrypsin-like proteolytic activity)..

A potent acetylcholinesterase (AChE) inhibitor with IC50 of 1.3 nM.

A potent acetylcholinesterase (AChE) inhibitor with IC50 of 1.3 nM.

A potent adenosine transport activity of ENT-1 with IC50 of 26.9 nM.

A potent AHR (aryl hydrocarbon receptor) agonist that induces degradation of AhR by the ubiquitin-proteasome pathway.

A potent and balanced dual PPARα/γ agonist (EC50= 50/21 nM).